Skip to main content
CARMAT logo

CARMAT — Investor Relations & Filings

Ticker · ALCAR ISIN · FR0010907956 LEI · 969500ARXACM0P0KH333 PA Manufacturing
Open in API
Filings indexed 570 across all filing types
Latest filing 2023-01-04 Regulatory Filings
Country FR France
Listing PA ALCAR

About CARMAT

https://www.carmatsa.com/en/

CARMAT is a medical technology company that designs, develops, and markets the Aeson® total artificial heart. This bioprosthetic device provides a therapeutic solution for patients suffering from end-stage biventricular heart failure. Aeson® is designed to replace the native heart, primarily as a bridge to transplantation for eligible patients. A key feature of the device is its self-regulation capability, which uses embedded sensors and biocompatible materials to automatically adapt blood flow based on the patient's physiological needs, thereby mimicking the function of a natural heart.

Recent filings

Filing Released Lang Actions
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 1% confidence The document is explicitly titled "COMMUNIQUE DE PRESSE" (Press Release) and announces a specific operational milestone: the first implantation of the Aeson® artificial heart in France as part of the EFICAS clinical study. It provides key dates, locations, study objectives, and quotes from management. This format—a brief, timely announcement of a significant corporate or operational event, rather than a comprehensive financial report (like 10-K or IR) or a transcript—aligns best with an Earnings Release (ER) or a general Regulatory Filing (RNS). Since it is not a formal financial results announcement (ER) but rather a specific operational update, and it doesn't fit the definitions for M&A (TAR), Capital Change (CAP), or Dividend (DIV), it falls under the general category for significant, non-standard regulatory announcements. Given the options, RNS (Regulatory Filings) is the most appropriate fallback for a press release detailing clinical progress, although it shares characteristics with an ER in terms of being a timely update. However, since it is a press release announcing a clinical milestone, and not a formal financial report or a specific regulatory form, RNS is the best fit as a general regulatory announcement.
2023-01-04 French
Inside Information / Other news releases
Regulatory Filings Classification · 1% confidence The document is explicitly titled "COMMUNIQUE DE PRESSE" (Press Release) and announces a specific operational milestone: the first implantation of the Aeson® artificial heart in France as part of the EFICAS clinical study. It provides key dates, locations, study objectives, and quotes from management. This format—a brief, timely announcement of a significant corporate or operational event, rather than a comprehensive financial report (like 10-K or IR) or a transcript—aligns best with an Earnings Release (ER) or a general Regulatory Filing (RNS). Since it is not a formal financial results announcement (ER) but rather a specific operational update, and it doesn't fit the definitions for M&A (TAR), Capital Change (CAP), or Dividend (DIV), it falls under the general category for significant, non-standard regulatory announcements. Given the options, RNS (Regulatory Filings) is the most appropriate fallback for a press release detailing clinical progress, although it shares characteristics with an ER in terms of being a timely update. However, since it is a press release announcing a clinical milestone, and not a formal financial report or a specific regulatory form, RNS is the best fit as a general regulatory announcement.
2023-01-04 English
Acquisition ou cession des actions de l'émetteur / Information relative au contrat de liquidité
Transaction in Own Shares Classification · 1% confidence The document is titled "COMMUNIQUE DE PRESSE" (Press Release) and specifically discusses the "Bilan semestriel du contrat de liquidité" (Semi-annual statement of the liquidity contract) as of December 30, 2022. It details the number of shares and cash balance held under the liquidity agreement, and summarizes the total purchases and sales executed during the second half of 2022. This type of regular disclosure regarding market making or liquidity provision activities is a specific corporate action announcement, often related to share transactions or capital management, but it is not a standard regulatory filing like 10-K, IR, or ER. Since it details transactions in the company's own shares (buy/sell activity managed by a third party under contract), it most closely aligns with the definition of 'Transaction in Own Shares' (POS), which covers share repurchase/issuance activities, even if managed via a liquidity contract. It is a specific announcement, not a general regulatory filing (RNS) or a report publication announcement (RPA).
2023-01-03 French
Inside Information / Other news releases
Board/Management Information Classification · 1% confidence The document is explicitly titled "PRESS RELEASE" and announces a significant change in corporate governance: the appointment of Alexandre Conroy as Chairman of the Board of Directors and the stepping down of the outgoing Chairman. This type of announcement, detailing changes in senior leadership or the board, directly corresponds to the definition of Board/Management Information (MANG). It is not an earnings release (ER), a full annual report (10-K), or a proxy statement (DEF 14A/PSI).
2022-12-22 English
Informations privilégiées / Autres communiqués
Board/Management Information Classification · 1% confidence The document is explicitly titled "COMMUNIQUE DE PRESSE" (Press Release) and announces a significant management change: the co-optation and appointment of Alexandre Conroy as Chairman of the Board, replacing the resigning Chairman. This directly corresponds to the definition of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management. The length (8584 chars) is substantial enough to be the primary announcement itself, not just a brief notification of a report.
2022-12-22 French
Inside Information / Other news releases
Capital/Financing Update Classification · 1% confidence The document is explicitly titled "PRESS RELEASE" and announces that CARMAT has been selected as a winner of the European Innovation Council (EIC) Accelerator, resulting in blended funding of up to €17.5m (a grant and potential equity investment). This type of announcement, detailing significant corporate funding, strategic partnerships, or major non-financial operational milestones via a press release format, most closely aligns with the 'Capital/Financing Update' category, as it directly concerns the company's financial resources and development support. It is not a full financial report (10-K or IR), a management discussion (MDA), or a formal regulatory filing like a DVA or DIV. Therefore, the appropriate code is CAP.
2022-12-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.